As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991. This surge stems primarily from prolonged outbreaks in under-vaccinated communities, with 94% of 2026 cases tied to ongoing transmission chains that began in late 2025, including major clusters in South Carolina and Utah. Low MMR vaccination coverage in affected populations sustains community spread, while most cases remain domestically acquired rather than importations. Weekly CDC surveillance updates and state health reports through late August will provide the final counts determining market resolution, with case trajectories sensitive to any new clusters or reporting lags.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCasos de sarampo nos EUA até 31 de agosto?
Casos de sarampo nos EUA até 31 de agosto?
NOVO
31 ago 2026
2.400+
100%
2450+
100%
2.500+
98%
2550+
94%
2600+
86%
$7,636 Vol.
2.400+
$2,169 Vol.
100%
2450+
$774 Vol.
100%
2.500+
$417 Vol.
98%
2550+
$932 Vol.
94%
2600+
$3,344 Vol.
86%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991. This surge stems primarily from prolonged outbreaks in under-vaccinated communities, with 94% of 2026 cases tied to ongoing transmission chains that began in late 2025, including major clusters in South Carolina and Utah. Low MMR vaccination coverage in affected populations sustains community spread, while most cases remain domestically acquired rather than importations. Weekly CDC surveillance updates and state health reports through late August will provide the final counts determining market resolution, with case trajectories sensitive to any new clusters or reporting lags.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado Aberto: Jul 31, 2026, 10:25 AM ET
Volume
$7,636Data de Término
31 ago 2026Mercado Aberto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991. This surge stems primarily from prolonged outbreaks in under-vaccinated communities, with 94% of 2026 cases tied to ongoing transmission chains that began in late 2025, including major clusters in South Carolina and Utah. Low MMR vaccination coverage in affected populations sustains community spread, while most cases remain domestically acquired rather than importations. Weekly CDC surveillance updates and state health reports through late August will provide the final counts determining market resolution, with case trajectories sensitive to any new clusters or reporting lags.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,636Data de Término
31 ago 2026Mercado Aberto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991. This surge stems primarily from prolonged outbreaks in under-vaccinated communities, with 94% of 2026 cases tied to ongoing transmission chains that began in late 2025, including major clusters in South Carolina and Utah. Low MMR vaccination coverage in affected populations sustains community spread, while most cases remain domestically acquired rather than importations. Weekly CDC surveillance updates and state health reports through late August will provide the final counts determining market resolution, with case trajectories sensitive to any new clusters or reporting lags.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions